CK Life Sciences Intl (Holdings) Inc

Chart & Performance

D1W1MN

P/E

339.87

P/S

1.10

EPS

0.00

Div Yield, %

—

Shrs. gr., 5y

—

Rev. gr., 5y

0.34%

Revenues

5.52b

+3.76%

Net income

-127m

CFO

-100.00%

Dividend

May 23, 20230.008 HKD/sh

Profile

CK Life Sciences Int'l., (Holdings) Inc., an investment holding company, researches, develops, manufactures, commercializes, markets, and sells health and agriculture-related products in the Asia Pacific and North America. It manufactures and markets plant protection products and soluble fertilizers; manufactures, blends, distributes, and sells fertilizers, pesticides, and related agricultural products; manufactures and distributes horticultural products for the home gardening market; and produces non-sterile prescription and over-the-counter medicines. The company is also involved in the contract manufacturing of complementary healthcare medicines, pharmaceutical products, and cosmetics; licensing of registration activities and the importation of finished agricultural goods; holding of land and buildings; financing activities; investment in financial instruments and vineyards; trading of biotechnology products and nutritional supplements; and manufacturing, wholesaling, retailing, and distribution of nutraceutical products. In addition, it distributes turf management machinery, hardware, equipment, and accessories, as well as turf fertilizers, chemicals, and professional pest products; produces, refines, and distributes salt products; and provides research and development services for biotechnology and life sciences technology products. Further, it researches, develops, manufactures, and commercializes drug products to treat pain and melanoma; supplies raw materials for nutritional health, pharmaceutical, cosmetics, personal care, and food segments; and offers packing and asset management services. CK Life Sciences Int'l., (Holdings) Inc. was founded in 1999 and is headquartered in Tai Po, Hong Kong.

URL

https://www.ck-lifesciences.com/

IPO date

Jul 16, 2002

Employees

1,887

Domiciled in

Incorporated in

Valuation

Order:

Title HKD in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title HKD in thousands, except ratios and share amounts	2024‑12	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12	2015‑12
Income
Revenues	5,522,674 3.76%	5,322,733 0.89%	5,275,590 -2.35%
Cost of revenue	4,084,219	3,966,375	3,946,213
Unusual Expense (Income)
NOPBT	1,438,455	1,356,358	1,329,377
NOPBT Margin	26.05%	25.48%	25.20%
Operating Taxes	35,072	51,334	72,912
Tax Rate	2.44%	3.78%	5.48%
NOPAT	1,403,383	1,305,024	1,256,465
Net income	(126,554) -833.65%	17,250 -86.93%	131,963 -18.94%
Dividends		(76,889)	(96,111)
Dividend yield		1.29%	1.27%
Proceeds from repurchase of equity
BB yield
Debt
Debt current	1,350,356	1,221,780	3,125,914
Long-term debt	5,374,084	5,217,489	3,335,920
Deferred revenue
Other long-term liabilities	214,399	9,701	8,142
Net debt	6,104,025	3,886,671	5,721,553
Cash flow
Cash from operating activities		514,181	363,659
CAPEX		(287,676)	(216,969)
Cash from investing activities		(67,961)	(22,119)
Cash from financing activities		(477,953)	(515,340)
FCF	35,001	1,178,527	1,419,056
Balance
Cash	571,212	676,163	704,125
Long term investments	49,203	1,876,435	36,156
Excess cash	344,281	2,286,461	476,502
Stockholders' equity	402,002	1,079,707	3,277,929
Invested Capital	9,481,335	9,050,355	9,575,590
ROIC	15.15%	14.01%	12.80%
ROCE	14.64%	13.08%	12.94%
EV
Common stock shares outstanding	9,611,073	9,611,073	9,611,073
Price	0.41 -33.87%	0.62 -21.52%	0.79 6.76%
Market cap	3,940,540 -33.87%	5,958,865 -21.52%	7,592,748 6.76%
EV	10,044,565	9,845,536	15,620,464
EBITDA	1,438,455	1,590,099	1,560,291
EV/EBITDA	6.98	6.19	10.01
Interest		322,425	163,092
Interest/NOPBT		23.77%	12.27%